abbvie glp-1 Healthy Returns: is the newest potential weight loss drug player 1 and CB2 receptors to help reduce appetite abbvie glp-1 receptor agonist weight

The A Study of Tirzepatide on the Reduction on Morbidity and Mortality in Adults with Obesity (SURMOUNT-MMO) trial assesses tirzepatide's impact on mortality and cardiovascular events in overweight or obese individuals

Plus, those taking Mounjaro generally feel fuller sooner and remain fuller for longer since the medication also slows digestion, which can help with hunger and portion control, she explains

Chiefari E, Capula C, Vero A, et al

Monitoring should include: Regular weight and BMI measurements Assessment of metabolic parameters Mental health screening and evaluation Monitoring for adverse events Assessment of medication adherence Evaluation of lifestyle behaviors Future Research Priorities Several critical research questions remain unanswered